# Vince Holding Corp.: financial statements, quarterly

VNCE · Nasdaq · CIK 1579157 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Feb 1

Pages: [Overview](/companies/vnce.md) · [Financials](/companies/vnce/financials.md) · [Filings](/companies/vnce/filings.md) · [Insiders](/companies/vnce/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vnce/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [84.1](/filings/0000950170-24-135830.md) | [75.3 d](/filings/0000950170-25-062847.md) | [59.2](/filings/0000950170-25-087465.md) | [74.2](/filings/0001579157-25-000008.md) | [80.2](/filings/0001193125-25-314362.md) | [80.0 d](/filings/0001193125-26-158986.md) | [57.9](/filings/0001193125-26-271897.md) | [73.2](/filings/0001193125-26-388635.md) | [85.1](/filings/0001193125-25-314362.md) | [83.7 d](/filings/0001193125-26-158986.md) | [64.0](/filings/0001193125-26-271897.md) | [81.8](/filings/0001193125-26-388635.md) |
| Cost of revenue | $m | [46.9](/filings/0000950170-24-135830.md) | [41.1 d](/filings/0000950170-25-062847.md) | [29.3](/filings/0000950170-25-087465.md) | [39.0](/filings/0001579157-25-000008.md) | [40.1](/filings/0001193125-25-314362.md) | [39.9 d](/filings/0001193125-26-158986.md) | [28.8](/filings/0001193125-26-271897.md) | [36.3](/filings/0001193125-26-388635.md) | [43.2](/filings/0001193125-25-314362.md) | [42.6 d](/filings/0001193125-26-158986.md) | [31.6](/filings/0001193125-26-271897.md) | [32.0](/filings/0001193125-26-388635.md) |
| Gross profit | $m | [37.2](/filings/0000950170-24-135830.md) | [34.2 d](/filings/0000950170-25-062847.md) | [29.9](/filings/0000950170-25-087465.md) | [35.1](/filings/0001579157-25-000008.md) | [40.1](/filings/0001193125-25-314362.md) | [40.1 d](/filings/0001193125-26-158986.md) | [29.2](/filings/0001193125-26-271897.md) | [36.9](/filings/0001193125-26-388635.md) | [41.9](/filings/0001193125-25-314362.md) | [41.1 d](/filings/0001193125-26-158986.md) | [32.4](/filings/0001193125-26-271897.md) | [49.8](/filings/0001193125-26-388635.md) |
| Selling, general and administrative | $m | [34.4](/filings/0000950170-24-135830.md) | [35.8 d](/filings/0000950170-25-062847.md) | [31.9](/filings/0000950170-25-087465.md) | [34.0](/filings/0001579157-25-000008.md) | [34.3](/filings/0001193125-25-314362.md) | [37.8 d](/filings/0001193125-26-158986.md) | [33.6](/filings/0001193125-26-271897.md) | [25.8](/filings/0001193125-26-388635.md) | [36.5](/filings/0001193125-25-314362.md) | [44.0 d](/filings/0001193125-26-158986.md) | [35.0](/filings/0001193125-26-271897.md) | [36.3](/filings/0001193125-26-388635.md) |
| Operating income | $m | [2.8](/filings/0000950170-24-135830.md) | [(1.7) d](/filings/0000950170-25-062847.md) | [5.6](/filings/0000950170-25-087465.md) | [1.1](/filings/0001579157-25-000008.md) | [5.8](/filings/0001193125-25-314362.md) | [(29.7) d](/filings/0001193125-26-158986.md) | [(4.4)](/filings/0001193125-26-271897.md) | [11.2](/filings/0001193125-26-388635.md) | [5.4](/filings/0001193125-25-314362.md) | [(2.9) d](/filings/0001193125-26-158986.md) | [(2.6)](/filings/0001193125-26-271897.md) | [13.6](/filings/0001193125-26-388635.md) |
| Interest expense | $m | [2.0](/filings/0000950170-24-135830.md) | [1.7 d](/filings/0000950170-25-062847.md) | [1.6](/filings/0000950170-25-087465.md) | [1.6](/filings/0001579157-25-000008.md) | [1.7](/filings/0001193125-25-314362.md) | [1.6 d](/filings/0001193125-26-158986.md) | [0.9](/filings/0001193125-26-271897.md) | [0.8](/filings/0001193125-26-388635.md) | [1.0](/filings/0001193125-25-314362.md) | [0.7 d](/filings/0001193125-26-158986.md) | [0.6](/filings/0001193125-26-271897.md) | [0.7](/filings/0001193125-26-388635.md) |
| Income tax | $m | [0.5](/filings/0000950170-24-135830.md) | [1.9 d](/filings/0000950170-25-062847.md) | [(0.9)](/filings/0000950170-25-087465.md) | [(0.8)](/filings/0001579157-25-000008.md) | [0.0](/filings/0001193125-25-314362.md) | [(2.0) d](/filings/0001193125-26-158986.md) | not reported | [0.1](/filings/0001193125-26-388635.md) | [2.0](/filings/0001193125-25-314362.md) | [0.5 d](/filings/0001193125-26-158986.md) | [(0.4)](/filings/0001193125-26-271897.md) | [3.1](/filings/0001193125-26-388635.md) |
| Net income | $m | [1.0](/filings/0000950170-24-135830.md) | [(4.7) d](/filings/0000950170-25-062847.md) | [4.4](/filings/0001193125-25-314362.md) | [0.6](/filings/0001193125-25-314362.md) | [4.3](/filings/0001193125-25-314362.md) | [(28.3) d](/filings/0001193125-26-158986.md) | [(4.8)](/filings/0001193125-26-388635.md) | [12.1](/filings/0001193125-26-388635.md) | [2.7](/filings/0001193125-25-314362.md) | [(3.6) d](/filings/0001193125-26-158986.md) | [(2.1)](/filings/0001193125-26-388635.md) | [10.6](/filings/0001193125-26-388635.md) |
| Diluted EPS | $ per share | [0.08](/filings/0000950170-24-135830.md) | not reported | [0.35](/filings/0000950170-25-087465.md) | [0.05](/filings/0001579157-25-000008.md) | [0.34](/filings/0001193125-25-314362.md) | not reported | [(0.37)](/filings/0001193125-26-271897.md) | [0.93](/filings/0001193125-26-388635.md) | [0.21](/filings/0001193125-25-314362.md) | not reported | [(0.16)](/filings/0001193125-26-271897.md) | [0.80](/filings/0001193125-26-388635.md) |
| Basic EPS | $ per share | [0.08](/filings/0000950170-24-135830.md) | not reported | [0.35](/filings/0000950170-25-087465.md) | [0.05](/filings/0001579157-25-000008.md) | [0.35](/filings/0001193125-25-314362.md) | not reported | [(0.37)](/filings/0001193125-26-271897.md) | [0.93](/filings/0001193125-26-388635.md) | [0.21](/filings/0001193125-25-314362.md) | not reported | [(0.16)](/filings/0001193125-26-271897.md) | [0.82](/filings/0001193125-26-388635.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.2](/filings/0000950170-24-135830.md) | [0.4](/filings/0000950170-25-062847.md) | [0.7](/filings/0000950170-25-087465.md) | [0.7](/filings/0001579157-25-000008.md) | [0.9](/filings/0001193125-25-314362.md) | [0.6](/filings/0001193125-26-158986.md) | [2.6](/filings/0001193125-26-271897.md) | [0.8](/filings/0001193125-26-388635.md) | [1.1](/filings/0001193125-25-314362.md) | [0.5](/filings/0001193125-26-388635.md) | [0.8](/filings/0001193125-26-271897.md) | [1.0](/filings/0001193125-26-388635.md) |
| Current assets | $m | [104](/filings/0000950170-23-068836.md) | [84.8](/filings/0000950170-25-062847.md) | [86.6](/filings/0000950170-24-074927.md) | [109](/filings/0000950170-24-107021.md) | [100](/filings/0000950170-24-135830.md) | [96.6](/filings/0001193125-26-158986.md) | [95.5](/filings/0000950170-25-087465.md) | [112](/filings/0001579157-25-000008.md) | [118](/filings/0001193125-25-314362.md) | [101](/filings/0001193125-26-388635.md) | [96.9](/filings/0001193125-26-271897.md) | [106](/filings/0001193125-26-388635.md) |
| Total assets | $m | [245](/filings/0000950170-23-068836.md) | [225](/filings/0000950170-25-062847.md) | [223](/filings/0000950170-24-074927.md) | [254](/filings/0000950170-24-107021.md) | [255](/filings/0000950170-24-135830.md) | [223](/filings/0001193125-26-158986.md) | [218](/filings/0000950170-25-087465.md) | [239](/filings/0001579157-25-000008.md) | [246](/filings/0001193125-25-314362.md) | [225](/filings/0001193125-26-388635.md) | [220](/filings/0001193125-26-271897.md) | [229](/filings/0001193125-26-388635.md) |
| Current liabilities | $m | [63.5](/filings/0000950170-23-068836.md) | [61.4](/filings/0000950170-25-062847.md) | [52.0](/filings/0000950170-24-074927.md) | [67.5](/filings/0000950170-24-107021.md) | [57.7](/filings/0000950170-24-135830.md) | [73.5](/filings/0001193125-26-158986.md) | [60.7](/filings/0000950170-25-087465.md) | [69.7](/filings/0001579157-25-000008.md) | [66.2](/filings/0001193125-25-314362.md) | [67.9](/filings/0001193125-26-388635.md) | [55.6](/filings/0001193125-26-271897.md) | [71.4](/filings/0001193125-26-388635.md) |
| Long-term debt | $m | [57.9](/filings/0000950170-23-068836.md) | [44.0](/filings/0000950170-25-062847.md) | [50.1](/filings/0000950170-24-074927.md) | [54.4](/filings/0000950170-24-107021.md) | [50.6](/filings/0000950170-24-135830.md) | [19.2](/filings/0001193125-26-158986.md) | [34.7](/filings/0000950170-25-087465.md) | [31.1](/filings/0001579157-25-000008.md) | [36.1](/filings/0001193125-25-314362.md) | [19.5](/filings/0001193125-26-388635.md) | [29.1](/filings/0001193125-26-271897.md) | [12.3](/filings/0001193125-26-388635.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [51.4](/filings/0000950170-24-135830.md) | [47.2](/filings/0001193125-26-158986.md) | [51.7](/filings/0001193125-25-314362.md) | [52.4](/filings/0001193125-25-314362.md) | [57.1](/filings/0001193125-25-314362.md) | [41.8](/filings/0001193125-26-388635.md) | [37.2](/filings/0001193125-26-388635.md) | [49.3](/filings/0001193125-26-388635.md) | [53.4](/filings/0001193125-25-314362.md) | [50.1](/filings/0001193125-26-388635.md) | [48.2](/filings/0001193125-26-388635.md) | [58.8](/filings/0001193125-26-388635.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.0 d](/filings/0000950170-24-135830.md) | [14.8 d](/filings/0000950170-25-062847.md) | [(3.9)](/filings/0000950170-25-087465.md) | [(3.2) d](/filings/0001579157-25-000008.md) | [6.4 d](/filings/0001193125-25-314362.md) | [22.7 d](/filings/0001193125-26-158986.md) | [(11.8)](/filings/0001193125-26-271897.md) | [4.2 d](/filings/0001193125-26-388635.md) | [(5.1) d](/filings/0001193125-25-314362.md) | [15.7 d](/filings/0001193125-26-158986.md) | [(8.9)](/filings/0001193125-26-271897.md) | [18.1 d](/filings/0001193125-26-388635.md) |
| Capital expenditure | $m | [0.5 d](/filings/0000950170-24-135830.md) | [0.5 d](/filings/0000950170-25-062847.md) | [0.7](/filings/0000950170-25-087465.md) | [0.7](/filings/0001579157-25-000008.md) | [1.3](/filings/0001193125-25-314362.md) | [1.5 d](/filings/0001193125-26-158986.md) | [1.4](/filings/0001193125-26-271897.md) | [2.1](/filings/0001579157-25-000008.md) | [0.6](/filings/0001193125-25-314362.md) | [0.1 d](/filings/0001193125-26-158986.md) | [0.2](/filings/0001193125-26-271897.md) | [0.7 d](/filings/0001193125-26-388635.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.3](/filings/0000950170-23-068836.md) | [12.3](/filings/0000950170-24-074927.md) | [12.5](/filings/0000950170-24-107021.md) | [12.5](/filings/0000950170-24-135830.md) | [12.6](/filings/0000950170-25-087465.md) | [12.6](/filings/0001579157-25-000008.md) | [12.7](/filings/0001193125-25-314362.md) | [12.8](/filings/0001193125-26-271897.md) | [13.0](/filings/0001193125-26-388635.md) | [13.2](/filings/0001193125-25-314362.md) | [12.8](/filings/0001193125-26-271897.md) | [13.2](/filings/0001193125-26-388635.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,944,749 at 2026-08-31, from the cover of the [10-Q filed 2026-09-11](/filings/0001193125-26-388635.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.